GB2008121A - Tetrapeptides - Google Patents

Tetrapeptides

Info

Publication number
GB2008121A
GB2008121A GB7841534A GB7841534A GB2008121A GB 2008121 A GB2008121 A GB 2008121A GB 7841534 A GB7841534 A GB 7841534A GB 7841534 A GB7841534 A GB 7841534A GB 2008121 A GB2008121 A GB 2008121A
Authority
GB
United Kingdom
Prior art keywords
methyl
hydrogen
alkyl
leu
ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7841534A
Other versions
GB2008121B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of GB2008121A publication Critical patent/GB2008121A/en
Application granted granted Critical
Publication of GB2008121B publication Critical patent/GB2008121B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser

Abstract

Tetrapeptides of formula: <IMAGE> wherein R<1> is hydrogen or C1-C6 alkyl; R<2> is hydrogen, C1-C6 alkyl or when R<1> is hydrogen, R<2> is allyl or cyclopropylmethyl; X<2> is D-Ala, D-Met, D-Nle, D-Leu, D-Pgl, D-Ser, S-methyl-D-Cys or C. Me-Ala; X<4> is N-methyl-Trp, N-methyl-Leu, N- methyl-Phe or N-methyl-His; and Y is -OM, wherein M is hydrogen, pharmaceutically acceptable cation, C1- C5 alkyl or Y is <IMAGE> wherein R<3> and R<4> are independently hydrogen or C1-C6 alkyl, or a pharmaceutically acceptable salt thereof, which produce an analgesic effect in warm blooded animals.
GB7841534A 1977-10-26 1978-10-23 Tetrapeptides Expired GB2008121B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84552377A 1977-10-26 1977-10-26

Publications (2)

Publication Number Publication Date
GB2008121A true GB2008121A (en) 1979-05-31
GB2008121B GB2008121B (en) 1982-03-17

Family

ID=25295420

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7841534A Expired GB2008121B (en) 1977-10-26 1978-10-23 Tetrapeptides

Country Status (1)

Country Link
GB (1) GB2008121B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254107A (en) * 1979-11-27 1981-03-03 Merck & Co., Inc. Long-lasting agonists of enkephalin
EP0030845A2 (en) * 1979-12-17 1981-06-24 Eli Lilly And Company Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254107A (en) * 1979-11-27 1981-03-03 Merck & Co., Inc. Long-lasting agonists of enkephalin
EP0030845A2 (en) * 1979-12-17 1981-06-24 Eli Lilly And Company Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
EP0030845A3 (en) * 1979-12-17 1981-11-04 Eli Lilly And Company Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GB2008121B (en) 1982-03-17

Similar Documents

Publication Publication Date Title
SE7412140L (en)
DE3060297D1 (en) 6-beta.7-beta; 15.16-dimethylene-1,4-androstadiene-3-ones, process for their preparation and their utilization in medicines
ES2051650A1 (en) Methods for scavenging active oxygen compounds and preventing damage from ultra violet B rays using taurine analogues
IE45576L (en) Analgesic tetrapeptides and pentapeptides
IT1093390B (en) SYSTEM FOR ADJUSTING THE FUEL INJECTION OF ENDOTHERMAL ENGINES
ATE141802T1 (en) ILLUDIN ANALOGUES USED AS ANTI-TUMOR AGENT
ZA796154B (en) Tablets
SG46413A1 (en) Substituted 4-phenyl-4-piperdinecarboxamides with both local anaesthetic and analgesic effect as well as processes for their preparation
ZA906506B (en) Halogenoalkylphenyl-alcohols,-ketons and hydrates thereof
ES2124256T3 (en) ARYLMORFOLINE, PREPARATION AND USE.
JPS57128666A (en) Peptides, manufacture and use as medicine
GB2008121A (en) Tetrapeptides
NO303926B1 (en) Use of imidazol-1-yl compounds for the preparation of pharmaceutical preparations
ES478874A1 (en) 3-0-( beta -D-Glucuronopyranosyl)-soyasapogenol B
SE8203053L (en) CYSTEIN DERIVATIVES IN THE FORM OF DISULFID
ES472467A1 (en) Process for the preparation of furanones and intermediate products in this process.
GB2014141A (en) 8???-ethyl- and 8???-methyl-4,5??? epoxymorphinan-6-one compounds
ES464377A1 (en) Stereoisomers of 1-(1{40 benzyl-2{40 pyrryl)-2-di-sec.-butylaminoethanol and pharmaceutical compositions comprising same
GB2027034B (en) Pentapeptides
ZA867397B (en) Alkylcarboxamides of pyridylalkylamines,their preparation and their use in human and veterinary medicine
GB2000784A (en) Analgestic Polypeptides
ES456639A1 (en) Cyclopenta{8 B{9 thiophene derivatives
ES469004A1 (en) Tetradeca peptides
JPS53127483A (en) Isoquinoline alcohols and their preparation
DE2861474D1 (en) Novel delta-4,9-pregnane derivatives, their use as progestational and/or ovulation-inhibiting agents and process for their preparation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee